Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL6059 Target Snapshot

DNA gyrase subunit B · SINGLE PROTEIN · Mycobacterium smegmatis (strain ATCC 700084 / mc(2)155)

59Compounds
3Assays
1Approved Drugs
59.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt A0QNE0. Use UniProt A0QNE0 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt A0QNE0 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats DNA gyrase subunit B as ChEMBL target CHEMBL6059, mapped to UniProt A0QNE0. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
DNA gyrase subunit B
SINGLE PROTEIN · Mycobacterium smegmatis (strain ATCC 700084 / mc(2)155)
As of 2026-09-14
ChEMBL target ID
CHEMBL6059
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
A0QNE0
DNA gyrase subunit B
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether DNA gyrase subunit B is the right protein anchor across sources, using UniProt A0QNE0 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelDNA gyrase subunit B
UniProt AccessionA0QNE0
Component TypeProtein
Sequence Length675 aa

DNA gyrase subunit B

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as DNA gyrase subunit B, mapped to UniProt A0QNE0. Sequence length is 675 aa.

Mapped IDA0QNE0
Review nameDNA gyrase subunit B
OrganismMycobacterium smegmatis (strain ATCC 700084 / mc(2)155)
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC5059.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL36506 7.34 IC50 46.0 Approved
CHEMBL3949206 5.6 IC50 2500.0 Preclinical
CHEMBL3941457 5.51 IC50 3100.0 Preclinical
CHEMBL3978320 5.38 IC50 4120.0 Preclinical
CHEMBL144307 5.26 IC50 5500.0 Preclinical
CHEMBL3898197 5.21 IC50 6100.0 Preclinical
CHEMBL3957846 5.17 IC50 6800.0 Preclinical
CHEMBL3968705 5.12 IC50 7600.0 Preclinical
CHEMBL3977363 5.12 IC50 7600.0 Preclinical
CHEMBL3967142 5.08 IC50 8300.0 Preclinical
Distribution

pChEMBL Value Distribution

12
5.0
2
5.5
0
6.0
0
6.5
1
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

NOVOBIOCIN
CHEMBL36506
Approved 1964
Assay Landscape

Assay Landscape

3
Total Assays
44
Tested Compounds
1
Assay Types
Binding — 3 assays, 44 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 2 44 4.9
single protein format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine